Fleseriu, Maria http://orcid.org/0000-0001-9284-6289
Biller, Beverly M. K.
Freda, Pamela U.
Gadelha, Monica R.
Giustina, Andrea
Katznelson, Laurence
Molitch, Mark E.
Samson, Susan L.
Strasburger, Christian J.
van der Lely, A. J.
Melmed, Shlomo http://orcid.org/0000-0002-2355-3447
Article History
Accepted: 28 September 2020
First Online: 20 October 2020
Compliance with ethical standards
:
: MF is a scientific consultant for Chiasma, Crinetics, Ipsen, Ionis, Novartis, Pfizer and Recordati and is a principal investigator with support to the institution for Chiasma, Crinetics, Ionis, and Novartis. BMKB is principal investigator of research support to the institution from Crinetics, Ionis, and Novartis, and received occasional consulting honoraria from Chiasma, Crinetics, and Novartis. PUF has received research grants to the institution for clinical research studies from Pfizer, Novartis, Ipsen, and Chiasma. MRG has served as principal investigator in clinical trials supported by Novartis and Crinetics, has served on advisory boards for Novartis and Crinetics, and served as a speaker for Novatis and Ipsen. AG is consultant for Chiasma, Genevant, Ipsen, Pfizer, and Recordati and received research grants from Ipsen, Novartis, and Pfizer to the institution. LK has received research support from Novartis and Chiasma, and has served as an advisor to Chiasma, Ionis, and Pfizer. MEM has research support from Chiasma, Novartis, Ionis, and Crinetics. SLS has served as an advisor and/or investigator for Novartis, Chiasma, Pfizer, and Ipsen, and has received investigator-initiated funding from Novartis. CJS served as an advisor to and received speaker’s fees from Pfizer, Ipsen, Chiasma, and Crinetics. AJVD served as an advisor to and received speaker’s fees from Pfizer, Ipsen, Amolyt, Tiburio, and Crinetics. SM is a consultant for Chiasma, Crinetics, Ionis, and Ipsen, and received a research grant from Pfizer to the institution.